AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.7 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access

Perilipin-1 Level as Risk Marker of Insulin Resistance in Morbidly Obese Patients

Hanaa Addai Ali1Ali Abbas Abo Algon2Shukryia Shadhan Chyad3Emad Abbas Jaffar Al-Mulla3( )
Department of Chemistry, Faculty of Science, University of Kufa, P.O. Box 21, An-Najaf 54001, Iraq
Pathological Department, Alkafeel University College, An-Najaf 54001, Iraq
College of Health and Medical Techniques, Al-Furat Al-Awsat Technical University, 54003 Al-Kufa, Iraq
Show Author Information

Abstract

Morbid obesity is a serious health condition that can interfere with basic physical functions such as breathing or walking. Those who are morbidly obese are at greater risk of illnesses including diabetes, high blood pressure, sleep apnea, gastro esophageal reflux disease, gallstones, osteoarthritis, heart disease, and cancer. This study was designed by taking 60 patients and 20 controls aged from 25 to 45 years with morbid obesity. A collection of samples was done by taking venous fasting blood samples from the patients and healthy volunteers after an overnight fasting. Insulin resistance (IR) was assessed using the homeostasis model assessment for insulin resistance (HOMA-IR), fasting blood glucose (FBG), glycated hemoglobin A1c (HbA1c) and lipid profile kits were used to determine these parameters. It was observed that the increase level of perilipin-1 led to insulin resistance and hyperinsulinemia for 60 patients, while the level of perilipin-1 in 20 controls caused insulin sensitivity. The increase of all studied parameters was concluded from the p-value, which was less than 0.05. The results also indicated that the level of perilipin-1 could be considered a risk factor for many diseases. It could cause accumulation of the bad cholesterol in vascular tissues leading to atherosclerosis; it could cause changes in many factors in secretion, could cause insulin resistance and then diabetes mellitus. The level of fatty acid coming from continuous lipolysis causes fatty liver and live diseases.

References

[1]

U.J. Jung, M.S. Choi, Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int. J. Mol. Sci., 2014, 15: 6184–6223.

[2]

R.F. Aten, K.M. Duarte, and H.R. Behrman, Regulation of ovarian antioxidant vitamins, reduced glutathione, and lipid peroxidation by luteinizing hormone and prostaglandin F2 α. Biol Reprod., 1992, 46: 401-407.

[3]

R.R. Al-Araji, M.S. Mashkour, and E.A.J. Al-Mulla, Spectrophotometric determination of vitamin folic acid B9 in some drugs using 1, 2-naphthoquine-4-sulphonate (NQS). Nano Biomed. Eng., 2017, 9(3): 208-213.

[4]

D.L. Brasaemle, Perilipin A increases triacylglycerol storage by decreasing the rate of triacylglycerol hydrolysis. J. Biol. Chem., 2000, 275: 38486–38493.

[5]

J.R. Skinner, L.-A.L.S. Harris, T.M. Shew, et al., Perilipin 1 moves between the fat droplet and the endoplasmic reticulum. Adipocyte, 2013, 2: 80-86.

[6]

H.K. Al-Hakeim, R.S. Al-Zabeba, and E. Grulke, Interaction of calcium phosphate nanoparticles with human chorionic gonadotropin modifies secondary and tertiary protein structure. Nova Biotechnologica et Chimica, 2015, 14 (2): 141-157.

[7]

M.M. Radhi, Z.N. Hamed, and S.S. Ezzaldeen, Effect of micro- and nanoparticles of ampicillin trihydrate on blood medium: A voltammetric study. Nano Biomed. Eng., 2017, 9(3): 185-190.

[8]

M.H. Moon, Antiobesity activity of a sphingosine 1-phosphate analogue FTY720 observed in adipocytes and obese mouse model. Experimental & Molecular Medicine, 2012, 44: 603.

[9]

Y.K. Amir, M.M. Radhi, Use of nano-sensors of the interferences between Pb(Ⅱ) with each of Mg(Ⅱ), Zn(Ⅱ), Mn(Ⅱ), Ca(Ⅱ), Co(Ⅱ) and PO4-3 in blood medium: An Electrochemical study. Nano Biomed. Eng., 2017, 9(3): 199-207.

[10]

K.H. Gathwan, I.T. Al-Karkhi, Hepatic toxicity of nickel chloride in mice. Res. Chem. Intermed., 2013, 39(6): 2537-2542.

[11]

R.E. Macpherson, Skeletal muscle PLIN3 and PLIN5 are serine phosphorylated at rest and following lipolysis during adrenergic or contractile stimulation. Physiol Rep 1, 2013, 84: 34-41.

[12]

T. Sawada, Perilipin overexpression in white adipose tissue induces a brown fat-like phenotype. PLoS One, 2010, 5: 22-29.

[13]

S.K. Malin, J. Bena, B. Abood, et al. Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgery. Diabetes, Obes. Metab., 2014, 16: 1230-1238.

[14]

J. Buteau, S. Foisy, C.J. Rhodes, et al., Protein kinase Czeta activation mediates glucagon-like peptide-1-induced pancreatic beta-cell proliferation. Diabetes, 2001, 50: 2237-2243.

[15]

J. Bi, Y. Xiang, H. Chen, et al., Opposite and redundant roles of the two Drosophila perilipins in lipid mobilization. Journal of Cell Science, 2012, 125: 3568-3577.

[16]

A. Afatoonian, H. Oskouian, S. Ahmadi, et al., Adipocytokine orosomucoid integrates inflammatory (2-6mm). J Assist Reprod Genet, 2009, 26: 319-325.

[17]

K. Alberti, Definition, diagnosis, and classification of diabetes mellitus and its complications. Part I: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Med., 1998, 15: 539-553.

[18]

J. Buyse, Adipose tissue and lipid metabolism. Sturkie’s Avian PhysioL., 2015, 23: 443-453.

[19]

B.J. Ashkenazi, Maternal obesity induces epigenetic modifications in overweight women. Reprod Biomed Online, 2010, 21:706-711.

[20]

J.T. Tansey, C. Sztalryd, E.M. Hlavin, et al., The central role of perilipin a in lipid metabolism and adipocyte lipolysis. IUBMB life, 2004, 56: 379-385.

[21]

S.M. Adams, V. Terry, M.J. Hosie, et al., The perilipin family of structural lipid droplet proteins regulated and natural cycles. Reprod Biol Endocrinol., 2004, 2: 21-29.

Nano Biomedicine and Engineering
Pages 285-290
Cite this article:
Ali HA, Algon AAA, Chyad SS, et al. Perilipin-1 Level as Risk Marker of Insulin Resistance in Morbidly Obese Patients. Nano Biomedicine and Engineering, 2017, 9(4): 285-290. https://doi.org/10.5101/nbe.v9i4.p285-290

488

Views

28

Downloads

0

Crossref

7

Scopus

Altmetrics

Received: 16 September 2017
Accepted: 06 November 2017
Published: 30 November 2017
© Hanaa addai Ali, Ali Abbas Abo Algon, Shukryia Shadhan Chyad, and Emad Abbas Jaffar Al-Mulla,

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Return